PVR and central nervous system cancer: Our observation of a more rounded, less mesenchymal morphology in CD155-depleted cells has been described previously in glioma cells (14), and studies in triple-negative aggressive breast cancer cells demonstrated CD155 contribution to the mesenchymal cell state (63).